UNSPSC 51422121: Mometasone furoate hydrate

This classification denotes a therapeutic glucocorticoid with the molecular formula C27H30Cl2O6.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MTW0WEG809, chemically known as pregna-1,4-diene-3,20-dione, 9,21-dichloro-17-((2-furanylcarbonyl)oxy)-11-hydroxy-16-methyl-, (11.beta.,16.alpha.)- monohydrate, but more generally known as mometasone furoate hydrate, which bears US NIH Compound Identifier 9893453.

European Medicines Agency schedules mometasone furoate hydrate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09045MIG. Most nations, for tariff purposes, schedule mometasone furoate hydrate under HS 29372200. SMILES: C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCL)OC(=O)C5CCCO5)C)O)CL)C.O.

UNSPSC 51422121 Mometasone furoate hydrate is a Commodity code for a specific topical corticosteroid pharmaceutical product. However, the recent state and local contract opportunities tagged under this code show minimal alignment with the nominal product scope — the two posted solicitations concern naloxone procurement and direct-to-manufacturer prescription program strategy rather than mometasone furoate hydrate acquisition. State and local governments do not appear to be actively soliciting this specific pharmaceutical ingredient through recent posted opportunities. The code shows little relevant recent activity, and the opportunities present suggest either a tagging error or an extremely thin solicitation stream under this Commodity designation.

No meaningful issuing-body patterns or geographic concentration emerge from the available records. Seminole County, Florida posted a competitive IFB for naloxone and drug deactivation systems with a response deadline of July 26, 2023, and the Texas Health and Human Services Commission issued an RFI on direct-to-manufacturer prescriptions with a response deadline of April 3, 2026 — neither of which targets mometasone furoate hydrate. Business development professionals evaluating this code should treat it as inactive for current state and local procurement purposes and monitor for future activity or clarification of the tagging approach.